跳至主要内容
临床试验/ACTRN12618001144202
ACTRN12618001144202已完成未知

Closed-loop oxygen control using a novel nasal high flow device during a six minute walk test in participants with chronic respiratory disease.

Fisher and Paykel Healtcare0 个研究点目标入组 42 人开始时间: 2018年7月12日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Doctor’s diagnosis of chronic respiratory disease, such as chronic obstructive pulmonary disease (COPD), interstitial lung disease or bronchiectasis
  • Age >18 years
  • SpO2 <90% during 6 minute walk test, demonstrated at visit one.
  • Stable respiratory state with no exacerbation in last 4 weeks

排除标准

  • Requirement for long term oxygen therapy (LTOT) or SpO2 <92% at rest
  • Presence of any absolute or relative (at investigator discretion) contraindications to 6 minute walk test as per ATS/ERS technical standard
  • Diagnosis of a notifiable disease
  • Infection or colonization with multidrug resistant bacteria, Pseudomonas species, Burkholderia Cepacia or mycobacteria
  • The presence of an implantable Medical Device
  • Any other condition which, at the investigator’s discretion, is believed may present a safety risk or impact the feasibility of the study or the study results.

研究者

发起方
Fisher and Paykel Healtcare

相似试验